Home NDC 51759-204-11 AJOVY
Product NDC 51759-204
Requested package NDC 51759-204-11
11-digit product format 517590204
Labeler code 51759
Product ID 51759-204_fc78e33c-331e-42e0-b780-3db6f5c108bd
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name fremanezumab-vfrm
Dosage form INJECTION
Route SUBCUTANEOUS
Labeler Teva Pharmaceuticals USA, Inc.
Application BLA761089
Marketing category BLA
Marketing start 2018-09-15
Substance FREMANEZUMAB
Active strength 225 mg/1.5mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Additional Listing Data#
Finished product Yes
Brand name base AJOVY
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FREMANEZUMAB 225 mg/1.5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination PF8K38CG54 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2056695 Internal RxNorm lookup 2056700 Internal RxNorm lookup 2287903 Internal RxNorm lookup 2287905 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51759-204-10 AJOVY 1.5 mL in 1 SYRINGE, GLASS INJECTION 1.5 23 51759-204-10 AJOVY 1 in 1 CARTON INJECTION 1 23 51759-204-11 AJOVY 1.5 mL in 1 SYRINGE, GLASS INJECTION 1.5 23 51759-204-11 AJOVY 1 in 1 CARTON INJECTION 1 23
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51759-204 AJOVY (FREMANEZUMAB-VFRM) INJECTION [TEVA PHARMACEUTICALS USA, INC.] 21 Current NDC, Legacy NDC, 4 package rows 20250328_98e344ea-5916-4947-b6f2-4a76ccc04b6b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761089 Ajovy fremanezumab-vfrm 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 51759-204-11 51759020411 1 SYRINGE, GLASS in 1 CARTON (51759-204-11) > 1.5 mL in 1 SYRINGE, GLASS 2018-09-15 2021-11-29 Yes No Current